IPSC Century Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: IPSC

Price (delayed)

$1.76

Market cap

$318.69M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.93

Enterprise value

$301.32M

?
Relative Growth: Rel. Growth: 11
Relative Strength: Rel. Strength: 92
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 1
Highlights
The debt has declined by 26% year-on-year and by 21% since the previous quarter
The EPS has increased by 18% since the previous quarter
The equity has declined by 12% since the previous quarter but it is up by 11% year-on-year
The revenue has dropped by 100% year-on-year
Century Therapeutics's gross profit has plunged by 100% YoY
Sector: Healthcare
Industry: Biotechnology
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of IPSC

IPSC stock price

How has the Century Therapeutics stock price performed over time
Intraday
-6.88%
1 week
-5.38%
1 month
-14.98%
1 year
262.59%
YTD
76.92%
QTD
-28.16%

Financial performance

How have Century Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$116.99M
Net income
-$109.79M
Gross margin
N/A
Net margin
N/A
The revenue has dropped by 100% year-on-year
Century Therapeutics's gross profit has plunged by 100% YoY

Price vs fundamentals

How does IPSC's price correlate with its fundamentals

Growth

What is Century Therapeutics's growth rate over time

Valuation

What is Century Therapeutics stock price valuation
P/E
N/A
P/B
1.37
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 18% since the previous quarter
IPSC's price to book (P/B) is 34% higher than its 5-year quarterly average of 1.1 and 34% higher than its last 4 quarters average of 1.1
The equity has declined by 12% since the previous quarter but it is up by 11% year-on-year
The revenue has dropped by 100% year-on-year

Efficiency

How efficient is Century Therapeutics business performance
The ROIC has contracted by 2.3% from the previous quarter

Dividends

What is IPSC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IPSC.

Financial health

How did Century Therapeutics financials performed over time
Century Therapeutics's total liabilities has decreased by 27% YoY and by 12% QoQ
The quick ratio has declined by 24% year-on-year and by 20% since the previous quarter
The debt is 85% smaller than the equity
IPSC's debt to equity is down by 32% year-on-year and by 12% since the previous quarter
The debt has declined by 26% year-on-year and by 21% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.